Unknown

Dataset Information

Adverse events of targeted therapies reported by patients with cancer treated in primary care.


ABSTRACT:

Background

Targeted Therapies (TT) are among the therapeutic innovations for cancer treatment in outpatient settings. TT-related Adverse Events (AEs) are a source of loss of opportunity for patients if their management is inappropriate.

Objectives

The objective of this study was to describe the AE frequency and severity as reported by patients with cancer who received TT in ambulatory settings. A second objective was to describe the role of the general practitioner (GP) in the management of AEs.

Methods

All patients who started TT at a French Regional Cancer Centre in 2017-2018 were eligible for this 12-month prospective study. A self-administered questionnaire was distributed at inclusion and returned after three months. In the questionnaire, patients listed all AEs

SUBMITTER: Roger S 

PROVIDER: S-EPMC7801082 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature